Tuesday, December 19, 2023 7:11:11 AM
Recent CGEN News
- Compugen shares jump nearly 5% after strong Q4 earnings beat • IH Market News • 03/02/2026 01:10:49 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/02/2026 12:16:01 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/02/2026 12:00:05 PM
- Compugen Reports Fourth Quarter and Full Year 2025 Results • PR Newswire (US) • 03/02/2026 12:00:00 PM
- Compugen to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/19/2026 12:00:00 PM
- Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026 • PR Newswire (US) • 02/17/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2026 12:00:48 PM
- Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors • PR Newswire (US) • 02/12/2026 12:00:00 PM
- Compugen Shares Jump After $65 Million Royalty Monetization Deal With AstraZeneca • IH Market News • 12/17/2025 03:00:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/17/2025 12:05:10 PM
- Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million • PR Newswire (US) • 12/17/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/10/2025 12:00:21 PM
- Compugen to Participate in Stifel 2025 Healthcare Conference • PR Newswire (US) • 11/04/2025 12:00:00 PM
- Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025 • PR Newswire (US) • 10/27/2025 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/14/2025 11:00:16 AM
- Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025 • PR Newswire (US) • 10/13/2025 11:00:00 AM
- Q3 Virtual Investor Summit: On-Demand Presentations Now Available • ACCESS Newswire • 09/30/2025 05:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/17/2025 11:00:18 AM
- Compugen to Present Research at the Single Cell Genomics 2025 Conference • PR Newswire (US) • 09/08/2025 11:00:00 AM
- Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference • PR Newswire (US) • 08/28/2025 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/06/2025 11:33:58 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/06/2025 11:01:16 AM
- Compugen Reports Second Quarter 2025 Results • PR Newswire (US) • 08/06/2025 11:00:00 AM
- Compugen to Present a Pooled Analysis of COM701 Phase 1 trials in Platinum Resistant Ovarian Cancer at ESMO 2025 • PR Newswire (US) • 07/28/2025 11:00:00 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
